BIOGEN IDEC INC (BIIB)

Overview Price 117.78 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $117.78 Daily Range $0.00 - $0.00 52-Week Range $65.39 - $123.23 Volume 100 IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases. Their first commercial product, Rituxan, and our most advanced product candidate, ZEVALIN, are for use in the treatment of certain B-cell non-Hodgkin's lymphomas. They are also developing products for the treatment of various autoimmune diseases (such as psoriasis, rheumatoid arthritis and lupus). Other Resources for BIIB Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Forget Big Pharma, It Is Time For A Biotech ETF February 9, 2012 Zacks Blog: The Zacks Analyst Blog Highlights: Pfizer, Biogen Idec, Elan, Novartis and Roche February 1, 2012 Zacks Blog: EPS Beat for Biogen; Outlook Weak January 31, 2012 Zacks Blog: Biogen & Elan Announce Tysabri Trial January 30, 2012 Zacks Blog: Earnings Preview: Biogen January 30, 2012 IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases. Their first commercial product, Rituxan, and our most advanced product candidate, ZEVALIN, are for use in the treatment of certain B-cellnon-Hodgkin's lymphomas. They are also developing products for the treatment of various autoimmune diseases (such as psoriasis, rheumatoidarthritis and lupus).   Brokerage Analyst Recommendations 18 Brokerage Firms Covering BIIB   Strong Buy 12 Buy 1 Hold 5 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1.61   BIIB Ratings: BUY  SELL  HOLD BIIB Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 50 Buy 0 Sell   Top Buy Analysis BUY: BIIB Company: BIOGEN IDEC INC Points: 20.82 Start Price: $97.34 Start Date: 05/09/2011 11:45 PM Neurodoc P&P Score: 99.60 Recs: maybe the best of new oral MS meds in the pipeline Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
rjm77me	99.92	02/09/12	One more shoe to drop = For market short term change of direction	9	02/09/12
Neurodoc	99.60	11/28/11	BG-12 assessment--I'm in the "yes" group	0
Neurodoc	99.60	06/22/11	Buy BIIB	0
zantriocom	0.00	07/20/10	Zantrio.com Free Daily Stock Picks 7-20-2010	0
zantriocom	0.00	04/20/10	Zantrio.com Free Daily Stock Picks 4-20-2010	0
zantriocom	0.00	02/09/10	Zantrio.com Free Daily Stock Picks 2-9-2010	0
AndrewGreenBull	97.65	02/08/10	Will GETA be another 10 Baggers in Early 2010?	4	03/12/10
zantriocom	0.00	09/08/09	Zantrio.com Stock Picks for September 8, 2009	0
Zacks_Analysts	0.00	01/31/12	EPS Beat for Biogen; Outlook Weak - Analyst Blog	0
Zacks_Analysts	0.00	01/30/12	Biogen & Elan Announce Tysabri Trial - Analyst Blog	0

Pages: [ 1 ]  2   3   4   5   ...  20  >>

Commentary

BUY: BIOGEN IDEC INC (BIIB) Start Price: $114.95 Points: -5.74 Created: 11/30/2011 IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases. Comments: 0 | Comment JDShots Recs:

BUY: BIOGEN IDEC INC (BIIB) Start Price: $97.34 Points: +20.82 Created: 05/09/2011 maybe the best of new oral MS meds in the pipeline Comments: 0 | Comment Neurodoc Recs:

BUY: BIOGEN IDEC INC (BIIB) Start Price: $59.90 Points: +82.99 Created: 10/25/2010 Breaking out of consolidation Comments: 0 | Comment wallstreeter Recs:

BUY: BIOGEN IDEC INC (BIIB) Start Price: $52.47 Points: +120.08 Created: 08/12/2008 Recent negative price gap due to possible side effects of Multiple Sclerosis Drug Tysabri will be resolved near term allowing price Target of 75 near term and 95 in 1st quarter 2009 Comments: 0 | Comment 2dimes Recs:

BUY: BIOGEN IDEC INC (BIIB) Start Price: $61.46 Points: +91.86 Created: 03/24/2008 great buyout---but could be very sucessful on its own. Comments: 0 | Comment band6 Recs:

BUY: BIOGEN IDEC INC (BIIB) Start Price: $117.85 Points: -2.39 Created: 01/26/2012 Comments: 0 | Comment vip Recs:

BUY: BIOGEN IDEC INC (BIIB) Start Price: $108.84 Points: -0.74 Created: 10/21/2011 Comments: 0 | Comment phillima Recs:

BUY: BIOGEN IDEC INC (BIIB) Start Price: $56.34 Points: +104.10 Created: 06/26/2008 Comments: 0 | Comment LeveneOMurray Recs:

BUY: BIOGEN IDEC INC (BIIB) Start Price: $64.67 Points: +85.67 Created: 04/27/2008 Comments: 0 | Comment ryno8888 Recs:

BUY: BIOGEN IDEC INC (BIIB) Start Price: $62.94 Points: +88.77 Created: 04/03/2008 Comments: 0 | Comment bella Recs:

Pages: [ 1 ]  2   3   4   5  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
vip	99.98	BUY	One to Three Months	01/26/2012	$117.85	$118.00 (-1.65%)	+0.13%	+2.52%	-2.39
JDShots	0.22	BUY	One to Three Months	11/30/2011	$114.95	$118.00 (-1.65%)	+2.65%	+8.40%	-5.74	view close
phillima	98.08	BUY	One to Three Months	10/21/2011	$108.84	$118.00 (-1.65%)	+8.42%	+9.16%	-0.74
Neurodoc	99.60	BUY	Six Months to a Year	05/09/2011	$97.34	$118.00 (-1.65%)	+21.22%	+0.40%	+20.82	view close
wallstreeter	0.23	BUY	Three to Six Months	10/25/2010	$59.90	$118.00 (-1.65%)	+96.99%	+14.01%	+82.99	view close
2dimes	21.03	BUY	One to Three Months	08/12/2008	$52.47	$118.00 (-1.65%)	+124.89%	+4.81%	+120.08	view close
LeveneOMurray	0.45	BUY	Week or Less	06/26/2008	$56.34	$118.00 (-1.65%)	+109.44%	+5.34%	+104.10
ryno8888	61.64	BUY	Six Months to a Year	04/27/2008	$64.67	$118.00 (-1.65%)	+82.46%	-3.20%	+85.67
bella	41.12	BUY	Three to Six Months	04/03/2008	$62.94	$118.00 (-1.65%)	+87.48%	-1.29%	+88.77
band6		BUY	Week to a Month	03/24/2008	$61.46	$118.00 (-1.65%)	+91.99%	+0.13%	+91.86	view close

Pages: [ 1 ]  2   3   4   5  >>